The Cancer Institute Hospital of the Japanese Foundation

Site:	The Cancer Institute Hospital of the Japanese Foundation
Address:
City:	Ariake
State:	Koto
Zip:	135-8550
Country:	Japan

Phase	Trial	Trial Status	Site Status	Drug	NCT#
1	Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer	Ongoing, but not recruiting	Closed	Cabozantinib	NCT01553656